Shares of Vivus Inc. rose almost 12 percent in pre-market trading Tuesday after the company reported results from a two-year study of its obesity drug Qnexa, and said the data demonstrate the drug’s safety.
Read this article:
Ahead of the Bell: Vivus rises on Qnexa study data
Popular Posts:
- Business leaders discuss new health care reform
- Advice on health care reform law offered at KC forums
- Sexy Teen Booty,Sexy health Care bill gave
- Health care reform topic of forum
- Health care reform topic of forum